Connection

José Aguado to L-Lactate Dehydrogenase

Back to Details
This is a "connection" page, showing publications José Aguado has written about L-Lactate Dehydrogenase.
José Aguado
Connection Strength
0.145
L-Lactate Dehydrogenase
  1. Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study. J Med Virol. 2021 02; 93(2):831-842.
    View in: PubMed
    Score: 0.116
  2. IL-6-based mortality risk model for hospitalized patients with COVID-19. J Allergy Clin Immunol. 2020 10; 146(4):799-807.e9.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.